Lyphe

Lyphe Group is a UK based medical cannabis pioneer that was founded in 2018. The company is involved in a range of activities, including product manufacturing, clinical care, pharmacy dispensing, and doctor education. Lyphe Group operates through its subsidiaries - Lyphe Clinic, The Academy of Medical Cannabis, and Dispensary Green. The group is dedicated to bringing medical cannabis treatments to patients who need them, with a focus on education for doctors, digital clinical care, manufacturing of cannabis medicines, and pharmacy home delivery direct to patients. This pioneer is a trusted entity, working with regulators, governments, the public, and partners to help patients across the world. The most recent funding for Lyphe Group is a £5.00M Series A investment, which was secured on 23 May 2022. The investors in this round include Leafy Tunnel and Sharp Capital Advisors. The company operates in the Health Care and Pharmaceutical sectors, showcasing its commitment to improving people's lives through the medical cannabis industry. With a strong emphasis on expertise and science, Lyphe Group is well-positioned to make a significant impact on the global medical cannabis landscape.